Zelluna Immunotherapy AS Sustainability Reports
Zelluna Immunotherapy AS is a biotechnology enterprise focused on developing an "off-the-shelf" allogeneic cell therapy platform using T-cell receptor guided natural killer cells (TCR-NK) to treat solid cancers.
Sector: Professional & technical services
Country: Norway
Exchange: Unlisted
LEI: 549300RGZDELJSZKBR24
3 reports from 2019 to 2023
